Exagen Inc. (XGN)
NASDAQ: XGN · Real-Time Price · USD
9.71
+0.15 (1.57%)
At close: Aug 13, 2025, 4:00 PM
9.67
0.00 (0.00%)
Pre-market: Aug 14, 2025, 8:59 AM EDT
Exagen Market Cap
Exagen has a market cap or net worth of $213.66 million as of August 14, 2025. Its market cap has increased by 517.98% in one year.
Market Cap
213.66M
Enterprise Value
208.04M
1-Year Change
517.98%
Ranking
Category
Stock Price
$9.71
Market Cap Chart
Since September 19, 2019, Exagen's market cap has increased from $63.11M to $213.66M, an increase of 238.57%. That is a compound annual growth rate of 22.94%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 592.95B |
| Johnson & Johnson | 420.06B |
| AbbVie | 355.91B |
| UnitedHealth Group | 246.17B |
| AstraZeneca | 240.81B |
| Novartis AG | 234.72B |
| Novo Nordisk | 227.37B |
| Abbott Laboratories | 225.22B |